RN7SL255P

Across TCGA pan-cancer cohorts, RN7SL255P RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of RN7SL255P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RN7SL255P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL255P is over-expressed in tumor.

COAD, LUSC, and HNSC are the cancer types where RN7SL255P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL255P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.301	<.001	6	view →
LUSC	All	All	+0.197	<.001	6	view →
HNSC	Male	II,III,IV	+0.134	.001	6	view →
LIHC	All	All	+0.088	.001	5	view →
STAD	All	II,III,IV	+0.297	.016	4	view →
BRCA	All	All	+0.176	.010	4	view →
LUAD	All	All	+0.147	.001	3	view →
READ	All	All	+0.303	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

RN7SL255P–COAD

Open the COAD breakdown →